PL353994A1 - Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives - Google Patents

Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Info

Publication number
PL353994A1
PL353994A1 PL00353994A PL35399400A PL353994A1 PL 353994 A1 PL353994 A1 PL 353994A1 PL 00353994 A PL00353994 A PL 00353994A PL 35399400 A PL35399400 A PL 35399400A PL 353994 A1 PL353994 A1 PL 353994A1
Authority
PL
Poland
Prior art keywords
mesoprogestins
component
receptor modulators
progesterone receptor
female contraceptives
Prior art date
Application number
PL00353994A
Other languages
English (en)
Polish (pl)
Inventor
KristofChwalisz Kristof Chwalisz
WalterElger Walter Elger
GerdSchubert Gerd Schubert
Original Assignee
Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg filed Critical Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg
Publication of PL353994A1 publication Critical patent/PL353994A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00353994A 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives PL353994A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31
PCT/IB2000/002053 WO2001026603A2 (fr) 1999-08-31 2000-08-31 Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins

Publications (1)

Publication Number Publication Date
PL353994A1 true PL353994A1 (en) 2003-12-15

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353994A PL353994A1 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Country Status (28)

Country Link
EP (1) EP1605949A2 (fr)
JP (1) JP2003511399A (fr)
KR (1) KR20020038745A (fr)
CN (1) CN1384748A (fr)
AR (1) AR025455A1 (fr)
AU (1) AU781835B2 (fr)
BG (1) BG106441A (fr)
BR (1) BR0013711A (fr)
CA (1) CA2383650A1 (fr)
CO (1) CO5190694A1 (fr)
CZ (1) CZ2002707A3 (fr)
EA (1) EA006805B1 (fr)
EE (1) EE200200103A (fr)
HR (1) HRP20020265A2 (fr)
HU (1) HUP0202515A3 (fr)
IL (1) IL148415A0 (fr)
LT (1) LT5001B (fr)
LV (1) LV12940B (fr)
MX (1) MXPA02002186A (fr)
NO (1) NO20020998L (fr)
NZ (1) NZ517470A (fr)
PE (1) PE20010579A1 (fr)
PL (1) PL353994A1 (fr)
SI (1) SI20853A (fr)
SK (1) SK2982002A3 (fr)
UA (1) UA77150C2 (fr)
WO (1) WO2001026603A2 (fr)
YU (1) YU13902A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014935A1 (fr) * 2002-08-02 2004-02-19 Schering Aktiengesellschaft Modulateurs de recepteurs de progesterone presentant une activite antigonadotrope augmentee, destines au controle de fertilite et au traitement hormonal substitutif chez la femme
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
CN104208067A (zh) * 2004-07-07 2014-12-17 惠氏公司 周期性黄体酮方案及试剂盒
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
EP3106167A1 (fr) 2009-04-14 2016-12-21 Laboratoire HRA Pharma Procédé de contraception à la demande
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
EP0559240B1 (fr) * 1987-09-24 2001-12-05 Jencap Research Limited Packages contraceptives contenant de l'estrogen et du progestin
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4447715C2 (de) 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Behandlung von Prostatakarzinomen
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP0787002B1 (fr) * 1994-10-24 2006-12-13 Schering Aktiengesellschaft Antagonistes competitifs de la progesterone permettant de reguler a la demande la fecondite feminine
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
PL330916A1 (en) * 1996-06-25 1999-06-07 Akzo Nobel Nv Progestagen-antiprogestagen dosing schemes
WO1998005679A2 (fr) * 1996-08-05 1998-02-12 Duke University Antagonistes mixtes du recepteur progesterone et techniques de dosage associees
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
WO2000066590A2 (fr) * 1999-05-04 2000-11-09 Ligand Pharmaceuticals, Inc. Composes modulateurs de recepteur de progesterone tetracycliques et procedes

Also Published As

Publication number Publication date
IL148415A0 (en) 2002-09-12
AU3215001A (en) 2001-04-23
EE200200103A (et) 2003-04-15
HUP0202515A2 (hu) 2002-12-28
WO2001026603A2 (fr) 2001-04-19
JP2003511399A (ja) 2003-03-25
PE20010579A1 (es) 2001-06-04
KR20020038745A (ko) 2002-05-23
AR025455A1 (es) 2002-11-27
NO20020998D0 (no) 2002-02-28
UA77150C2 (en) 2006-11-15
LT5001B (lt) 2003-03-25
NO20020998L (no) 2002-03-14
EA006805B1 (ru) 2006-04-28
SI20853A (sl) 2002-10-31
HUP0202515A3 (en) 2004-06-28
CZ2002707A3 (cs) 2002-11-13
SK2982002A3 (en) 2002-07-02
CN1384748A (zh) 2002-12-11
BR0013711A (pt) 2002-05-07
MXPA02002186A (es) 2002-09-02
YU13902A (sh) 2006-01-16
EP1605949A2 (fr) 2005-12-21
CA2383650A1 (fr) 2001-04-19
LT2002035A (lt) 2002-10-25
HRP20020265A2 (en) 2004-02-29
CO5190694A1 (es) 2002-08-29
AU781835B2 (en) 2005-06-16
BG106441A (bg) 2002-09-30
EA200200284A1 (ru) 2002-10-31
WO2001026603A3 (fr) 2002-01-17
NZ517470A (en) 2004-03-26
LV12940B (en) 2003-06-20

Similar Documents

Publication Publication Date Title
EG25606A (en) Glucocorticoid receptor modulators
HUP0203680A3 (en) Controlled release hydrocodone formulations
AU4686100A (en) Primary connector for pre-cast structures
IL147485A0 (en) Pharmaceutical compositions containing a selective estrogen receptor modulator
HUP0105463A3 (en) Controlled release formulation of divalproex sodium
AU3950600A (en) Intrauterine contraceptive device
HU0104534D0 (en) Process for the preparation of non-steroidal glucocorticoid receptor modulators
EP1189597A4 (fr) Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes
AU5025300A (en) Compositions for controlled release of the hormone gnrh and its analogs
MXPA01011294A (es) Compuestos moduladores de receptor de progesterona tetraciclicos y metodos.
IL154984A0 (en) Estrogen receptor modulators
HUP0202515A3 (en) Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
AU9621598A (en) Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
SG114650A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
GB0121486D0 (en) Processes for the preparation of Α-Aminoketones
GB9927215D0 (en) Hormone receptor expression
HUP0202460A3 (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
AU5550099A (en) A novel retinal nuclear hormone receptor
AU5545400A (en) Estrogen receptor
AU1901401A (en) Condom set for preventing premature ejaculation
SG100688A1 (en) Enzymatic resolution of selective estrogen receptor modulators
HK1043789A1 (zh) 作为黄体酮受体调节剂的环硫代胺基甲酸盐衍生物
HK1043989A1 (zh) 作为黄体酮受体调节剂的环胺基甲酸盐衍生物
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)